aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.